Erluo Chen
About
Erluo Chen is a scholar working on Oncology, Orthopedics and Sports Medicine and Surgery.
According to data from OpenAlex, Erluo Chen has authored 52 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Orthopedics and Sports Medicine and 13 papers in Surgery. Recurrent topics in Erluo Chen's work include Bone health and osteoporosis research (14 papers), Bone health and treatments (12 papers) and Lipoproteins and Cardiovascular Health (6 papers). Erluo Chen is often cited by papers focused on Bone health and osteoporosis research (14 papers), Bone health and treatments (12 papers) and Lipoproteins and Cardiovascular Health (6 papers). Erluo Chen collaborates with scholars based in United States, Canada and Japan. Erluo Chen's co-authors include C. David Naylor, William Geerts, Anne E. de Papp, Richard A. Petruschke, Neil Binkley, Mary K. Beard, Michael F. Holick, Ethel S. Siris, Aliya Khan and Mathew Sermer and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Annals of Internal Medicine.
In The Last Decade
Erluo Chen
51 papers receiving 6.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Erluo Chen United States | 27 | 1.6k | 1.5k | 1.4k | 1.3k | 1.2k | 52 | 6.6k | ||
| Catherine Stehman‐Breen United States | 49 | 1.5k 1.0× | 809 0.6× | 561 0.4× | 279 0.2× | 393 0.3× | 75 | 10.0k | ||
| Takashi Akiba Japan | 50 | 1.7k 1.1× | 356 0.2× | 934 0.7× | 190 0.1× | 795 0.7× | 252 | 10.3k | ||
| Tanya M. Petterson United States | 42 | 3.3k 2.1× | 457 0.3× | 942 0.7× | 8.5k 6.4× | 264 0.2× | 104 | 12.9k | ||
| Wendy Lim Canada | 41 | 2.4k 1.5× | 319 0.2× | 814 0.6× | 4.3k 3.3× | 111 0.1× | 112 | 10.0k | ||
| C S McArdle United Kingdom | 45 | 2.8k 1.8× | 4.5k 3.0× | 620 0.5× | 108 0.1× | 673 0.6× | 157 | 7.7k | ||
| Paul A. Kyrle Austria | 52 | 2.6k 1.7× | 500 0.3× | 154 0.1× | 5.8k 4.4× | 148 0.1× | 209 | 11.8k | ||
| Dongjie Fan United States | 18 | 1.8k 1.1× | 231 0.2× | 470 0.3× | 328 0.2× | 130 0.1× | 38 | 11.1k | ||
| Grace L. Smith United States | 44 | 1.3k 0.8× | 2.4k 1.6× | 792 0.6× | 35 0.0× | 213 0.2× | 205 | 8.9k | ||
| Catherine Nelson‐Piercy United Kingdom | 47 | 1.2k 0.7× | 299 0.2× | 298 0.2× | 1.1k 0.8× | 149 0.1× | 247 | 7.9k | ||
| Maria Grazia Valsecchi Italy | 49 | 626 0.4× | 870 0.6× | 460 0.3× | 153 0.1× | 580 0.5× | 246 | 7.7k |
Countries citing papers authored by Erluo Chen
Since
Specialization
Citations
This map shows the geographic impact of Erluo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erluo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erluo Chen more than expected).
Fields of papers citing papers by Erluo Chen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Erluo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erluo Chen. The network helps show where Erluo Chen may publish in the future.
Co-authorship network of co-authors of Erluo Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Erluo Chen. A scholar is included among the top collaborators of Erluo Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erluo Chen. Erluo Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ryoo, Baek‐Yeol, Philippe Merle, Amit S. Kulkarni, et al.. (2020). Health‐related quality‐of‐life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE‐240. Cancer. 127(6). 865–874.
2.
Finn, Richard S., Baek‐Yeol Ryoo, Philippe Merle, et al.. (2019). Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial. Journal of Clinical Oncology. 38(3). 193–202.
3.
Brinton, Eliot A., Joseph Triscari, Philippe Brudi, et al.. (2016). Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes. Lipids in Health and Disease. 15(1). 116–116.
4.
Ponikowski, Piotr, Veselin Mitrović, Christopher M. O’Connor, et al.. (2010). Haemodynamic Effects of Rolofylline in the Treatment of Patients with Heart Failure and Impaired Renal Function. European Journal of Heart Failure. 12(11). 1238–1246.
5.
Papp, Anne E. de, Henry G. Bone, Michael P. Caulfield, et al.. (2007). A cross-sectional study of bone turnover markers in healthy premenopausal women. Bone. 40(5). 1222–1230.
6.
Bonnick, Sydney Lou, Kenneth G. Saag, Douglas P. Kiel, et al.. (2006). Comparison of Weekly Treatment of Postmenopausal Osteoporosis with Alendronate Versus Risedronate Over Two Years. Obstetrical & Gynecological Survey. 62(1). 35–36.
7.
Rosen, Clifford J., Marc C. Hochberg, Sydney Lou Bonnick, et al.. (2005). Treatment With Once-Weekly Alendronate 70 mg Compared With Once-Weekly Risedronate 35 mg in Women With Postmenopausal Osteoporosis: A Randomized Double-Blind Study. Journal of Bone and Mineral Research. 20(1). 141–151.
8.
Cryer, Byron, Neil Binkley, Christine Simonelli, et al.. (2005). A randomized, placebo-controlled, 6-month study of once-weekly alendronate oral solution for postmenopausal osteoporosis. The American journal of geriatric pharmacotherapy. 3(3). 127–136.
9.
Chang, David J., Paul J. Desjardins, Steven Bird, et al.. (2004). Comparison of rofecoxib and a multidose oxycodone/acetaminophen regimen for the treatment of acute pain following oral surgery: a randomized controlled trial. Current Medical Research and Opinion. 20(6). 939–949.
10.
Rubin, Bernard R., Sandra Navarra, John Londoño, et al.. (2004). Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: A randomized controlled trial. Arthritis & Rheumatism. 50(2). 598–606.
11.
Sebba, Anthony, Sydney Lou Bonnick, Risa Kagan, et al.. (2004). Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis. Current Medical Research and Opinion. 20(12). 2031–2041.
12.
Luckey, Marjorie M., Risa Kagan, Susan L. Greenspan, et al.. (2004). Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis*. Menopause The Journal of The North American Menopause Society. 11(4). 405–415.
13.
Chang, David J., et al.. (2002). Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: A randomized, placebo-controlled clinical trial. Clinical Therapeutics. 24(4). 490–503.
14.
Richardson, Harold, et al.. (1996). An Assessment of the Utilization of Diagnostic Parasitology Laboratory Services in Ontario. Canadian Journal of Infectious Diseases and Medical Microbiology. 7(4). 237–242.
15.
Wong, David, Colina Yim, Erluo Chen, et al.. (1995). Interferon alfa treatment of chronic hepatitis B: Randomized trial in a predominantly homosexual male population. Gastroenterology. 108(1). 165–171.
16.
Sermer, Mathew, C. David Naylor, Douglas J. Gare, et al.. (1994). Impact of time since last meal on the gestational glucose challenge test. American Journal of Obstetrics and Gynecology. 171(3). 607–616.
17.
Naylor, C. David & Erluo Chen. (1994). Population-wide mortality trends among patients hospitalized for acute myocardial infarction: The Ontario experience, 1981 to 1991. Journal of the American College of Cardiology. 24(6). 1431–1438.
18.
Christakis, George T., Stephen E. Fremes, Steven Harwood, et al.. (1994). Determinants of low systemic vascular resistance during cardiopulmonary bypass. The Annals of Thoracic Surgery. 58(4). 1040–1049.
19.
Cox, Jafna L., Erluo Chen, & C. David Naylor. (1994). Revascularization after acute myocardial infarction. Journal of General Internal Medicine. 9(12). 674–678.
20.
Christakis, George T., et al.. (1993). Does Coronary Endarterectomy Adversely Affect the Results of Bypass Surgery?. Journal of Cardiac Surgery. 8(1). 72–78.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Catherine Stehman‐Breen Breakdown of academic impact, for papers by Takashi Akiba Breakdown of academic impact, for papers by Tanya M. Petterson Breakdown of academic impact, for papers by Wendy Lim Breakdown of academic impact, for papers by C S McArdle Breakdown of academic impact, for papers by Paul A. Kyrle Breakdown of academic impact, for papers by Dongjie Fan Breakdown of academic impact, for papers by Grace L. Smith Breakdown of academic impact, for papers by Catherine Nelson‐Piercy Breakdown of academic impact, for papers by Maria Grazia Valsecchi